Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
3(38%)
Results Posted
33%(1 trials)
Terminated
1(13%)

Phase Distribution

Ph not_applicable
2
25%
Ph phase_1
4
50%
Ph phase_4
1
13%
Ph phase_2
1
13%

Phase Distribution

4

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(1)

Detailed Status

Completed3
Recruiting2
Active, not recruiting1
unknown1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (50.0%)
Phase 21 (12.5%)
Phase 41 (12.5%)
N/A2 (25.0%)

Trials by Status

active_not_recruiting113%
recruiting225%
completed338%
unknown113%
terminated113%

Recent Activity

3 active trials
Showing 5 of 8
recruitingnot_applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

NCT06382818
active_not_recruitingphase_1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

NCT04280536
recruitingphase_2

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

NCT07125391
completedphase_1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

NCT06640920
terminatednot_applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

NCT03189381
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06382818Not Applicable

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Recruiting
NCT04280536Phase 1

Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA)

Active Not Recruiting
NCT07125391Phase 2

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer

Recruiting
NCT06640920Phase 1

A Study to Investigate Efficacy and Safety of NSI-8226 in Healthy Participants

Completed
NCT03189381Not Applicable

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Terminated
NCT03430479Phase 1

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

Completed
NCT04389775Phase 1

To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants

Completed
NCT02910375Phase 4

Golimumab Dried Blood Spot Analysis

Unknown

All 8 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
8